Summary
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) on September 29, 2003, is primarily a Regulation FD disclosure. The company announced that its officers were scheduled to meet with securities analysts and investors during the week of September 29, 2003. During these meetings, Anthem expected to reaffirm its ability to meet the earnings expectations previously communicated in a press release and conference call on July 31, 2003. This communication serves to provide assurance to the market regarding the company's financial performance outlook.
Key Highlights
- 1Anthem, Inc. (now Elevance Health) confirms its expectation to meet previously issued earnings guidance.
- 2Management scheduled meetings with securities analysts and investors during the week of September 29, 2003.
- 3The company is referencing a July 31, 2003 press release and conference call for the initial earnings expectations.
- 4This filing is a disclosure under Regulation FD, ensuring fair and timely dissemination of material information.
- 5The company reiterated that its forward-looking statements are subject to risks and uncertainties, as detailed in previous SEC filings.
- 6Michael L. Smith, Executive Vice President and Chief Financial and Accounting Officer, signed the report.
- 7The filing provides the company's principal executive office address in Indianapolis, Indiana.
Frequently Asked Questions
The main purpose of this 8-K filing is to serve as a Regulation FD disclosure, informing the market that Anthem, Inc.'s management planned to meet with analysts and investors and reaffirm their commitment to meeting previously issued earnings expectations.
The key earnings expectations are those that were initially communicated to the market through a press release and conference call on July 31, 2003. This 8-K serves to confirm that management expects to meet those specific targets.
No, this filing does not provide new financial results or projections. Instead, it confirms the company's expectation to meet previously stated earnings guidance and highlights the context of upcoming meetings with analysts and investors.
The filing broadly refers to risks and uncertainties detailed in Anthem's previous SEC filings. These include trends in healthcare costs and utilization, premium rate increases, competitor pricing, government regulation, acquisition integration (specifically Trigon Healthcare, Inc.), and general economic downturns, among others. Investors are cautioned not to place undue reliance on forward-looking statements.